SCHEMBL16144656

SCHEMBL16144656

CCNc1ccc(NC(=O)OC)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.62
SMN1; SMN2 Q16637 5/20 0.62
HPGD P15428 2/20 0.53
RAB9A P51151 4/20 0.50
NPC1 O15118 3/20 0.50
ALDH1A1 P00352 4/20 0.46
LMNA P02545 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46
GFER P55789 1/20 0.46
CASP1 P29466 1/20 0.45
ADRA2A P08913 1/20 0.45
MEN1 O00255 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609808 0.85 SMN1; SMN2 (0.82) MAPTSMN1; SMN2HPGDRAB9ANPC1
SCHEMBL5106835 0.82 CYP17A1 (0.54) MAPT
SCHEMBL11661313 0.81 MAPT (0.59) MAPTSMN1; SMN2HPGDRAB9ANPC1
SCHEMBL11790359 0.80 RAB9A (0.65) MAPTSMN1; SMN2HPGDRAB9ANPC1
SCHEMBL6002799 0.80 MAPT (0.62) MAPTSMN1; SMN2HPGDRAB9ANPC1
SCHEMBL28098568 0.79 SMN1; SMN2 (0.56) MAPTSMN1; SMN2HPGDRAB9ANPC1
SCHEMBL4579588 0.79 SMN1; SMN2 (0.61) MAPTSMN1; SMN2HPGDRAB9ANPC1
SCHEMBL18171766 0.79 LMNA (0.50) MAPTHPGDRAB9ANPC1ALDH1A1
SCHEMBL6082066 0.79 RAB9A (0.68) MAPTSMN1; SMN2HPGDRAB9ANPC1
SCHEMBL7251623 0.79 SMN1; SMN2 (0.72) MAPTSMN1; SMN2HPGDRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107771176-A The inhibitor of human immunodeficiency virus replication VIIV保健英国第五有限公司 2018-03-06 CN disclosed
WO-2014160592-A2 FACTOR XIa INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-10-02 WO disclosed